Recent studies indicate that insulin-like growth factor-II (IGF-II) acts as an autocrine differentiation factor for skeletal myoblasts in culture. IGF-II mRNA and protein are induced as early events in muscle differentiation, and the rate and extent of IGF-II secretion correlate with both biochemical and morphological differentiation. Here we show that IGF-II also functions as an essential survival factor during the transition from proliferating to differentiating myoblasts. Stably transfected C2 muscle cell lines were established in which a mouse IGF-II cDNA was expressed in the antisense orientation relative to the constitutively active Moloney sarcoma virus promoter. IGF-II antisense cells proliferated normally in growth medium containing 20% serum but underwent rapid death when placed in low serum differentiation medium. Death was accompanied by characteristic markers of apoptosis with more than 90% of cells showing DNA fragmentation within 12-16 h. Myoblast death was prevented by IGF-I, des [1-3] IGF-I, IGF-II, and insulin with a dose potency consistent with activation of the IGF-I receptor; death also could be blocked by the protein synthesis inhibitor, cycloheximide. Exogenous IGFs additionally stimulated passage through a single cell cycle and subsequently induced terminal differentiation. Cell survival and cell cycle progression also were enhanced by fibroblast growth factor-2 and platelet-derived growth factor-bb, but these peptides did not promote differentiation. Our results define a novel system for studying apoptotic cell death and its prevention by growth factors, underscore the importance of IGF action in minimizing inappropriate cell death, and indicate that shared signal transduction pathways may mediate myoblast survival in vitro.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				N. Al-Shanti and C. E Stewart PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059 J. Endocrinol., July 1, 2008; 198(1): 243 - 252. [Abstract] [Full Text] [PDF]

				C. Nevado, M. Benito, and A. M. Valverde Role of Insulin Receptor and Balance in Insulin Receptor Isoforms A and B in Regulation of Apoptosis in Simian Virus 40-immortalized Neonatal Hepatocytes Mol. Biol. Cell, March 1, 2008; 19(3): 1185 - 1198. [Abstract] [Full Text] [PDF]

				A. Mukherjee, E. M. Wilson, and P. Rotwein Insulin-Like Growth Factor (IGF) Binding Protein-5 Blocks Skeletal Muscle Differentiation by Inhibiting IGF Actions Mol. Endocrinol., January 1, 2008; 22(1): 206 - 215. [Abstract] [Full Text] [PDF]

				K. Nakanishi, N. Dohmae, and N. Morishima Endoplasmic reticulum stress increases myofiber formation in vitro FASEB J, September 1, 2007; 21(11): 2994 - 3003. [Abstract] [Full Text] [PDF]

				C. U. Niesler, K. H. Myburgh, and F. Moore Muscle: The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis Exp Physiol, January 1, 2007; 92(1): 207 - 217. [Abstract] [Full Text] [PDF]

				D. Kuninger, A. Wright, and P. Rotwein Muscle cell survival mediated by the transcriptional coactivators p300 and PCAF displays different requirements for acetyltransferase activity Am J Physiol Cell Physiol, October 1, 2006; 291(4): C699 - C709. [Abstract] [Full Text] [PDF]

				D. Kuninger, R. Kuns-Hashimoto, R. Kuzmickas, and P. Rotwein Complex biosynthesis of the muscle-enriched iron regulator RGMc J. Cell Sci., August 15, 2006; 119(16): 3273 - 3283. [Abstract] [Full Text] [PDF]

				M. Grohmann, E. Foulstone, G. Welsh, J. Holly, J. Shield, E. Crowne, and C. Stewart Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNF{alpha} J. Physiol., October 1, 2005; 568(1): 229 - 242. [Abstract] [Full Text] [PDF]

				A. A. Arslan, L. I. Gold, K. Mittal, T.-C. Suen, I. Belitskaya-Levy, M.-S. Tang, and P. Toniolo Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review Hum. Reprod., April 1, 2005; 20(4): 852 - 863. [Abstract] [Full Text] [PDF]

				M. A. Schrager, S. M. Roth, R. E. Ferrell, E. J. Metter, E. Russek-Cohen, N. A. Lynch, R. S. Lindle, and B. F. Hurley Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span J Appl Physiol, December 1, 2004; 97(6): 2176 - 2183. [Abstract] [Full Text] [PDF]

				S. R. Broussard, R. H. McCusker, J. E. Novakofski, K. Strle, W. H. Shen, R. W. Johnson, R. Dantzer, and K. W. Kelley IL-1{beta} Impairs Insulin-Like Growth Factor I-Induced Differentiation and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts J. Immunol., June 15, 2004; 172(12): 7713 - 7720. [Abstract] [Full Text] [PDF]

				L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function J. Cell Sci., May 1, 2004; 117(9): 1737 - 1746. [Abstract] [Full Text] [PDF]

				S. Croci, L. Landuzzi, A. Astolfi, G. Nicoletti, A. Rosolen, F. Sartori, M. Y. Follo, N. Oliver, C. De Giovanni, P. Nanni, et al. Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells Cancer Res., March 1, 2004; 64(5): 1730 - 1736. [Abstract] [Full Text] [PDF]

				A. Safi, M. Vandromme, S. Caussanel, L. Valdacci, D. Baas, M. Vidal, G. Brun, L. Schaeffer, and E. Goillot Role for the Pleckstrin Homology Domain-Containing Protein CKIP-1 in Phosphatidylinositol 3-Kinase-Regulated Muscle Differentiation Mol. Cell. Biol., February 1, 2004; 24(3): 1245 - 1255. [Abstract] [Full Text] [PDF]

				E. M. Wilson, M. M. Hsieh, and P. Rotwein Autocrine Growth Factor Signaling by Insulin-like Growth Factor-II Mediates MyoD-stimulated Myocyte Maturation J. Biol. Chem., October 17, 2003; 278(42): 41109 - 41113. [Abstract] [Full Text] [PDF]

				L. K. McLoon and S. P. Christiansen Increasing Extraocular Muscle Strength with Insulin-like Growth Factor II Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3866 - 3872. [Abstract] [Full Text] [PDF]

				M. L. Hribal, J. Nakae, T. Kitamura, J. R. Shutter, and D. Accili Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors J. Cell Biol., August 18, 2003; 162(4): 535 - 541. [Abstract] [Full Text] [PDF]

				S. R. Broussard, R. H. MCCusker, J. E. Novakofski, K. Strle, W. Hong Shen, R. W. Johnson, G. G. Freund, R. Dantzer, and K. W. Kelley Cytokine-Hormone Interactions: Tumor Necrosis Factor {alpha} Impairs Biologic Activity and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts Endocrinology, July 1, 2003; 144(7): 2988 - 2996. [Abstract] [Full Text] [PDF]

				O. Ostrovsky and E. Bengal The Mitogen-activated Protein Kinase Cascade Promotes Myoblast Cell Survival by Stabilizing the Cyclin-dependent Kinase Inhibitor, p21WAF1 Protein J. Biol. Chem., May 30, 2003; 278(23): 21221 - 21231. [Abstract] [Full Text] [PDF]

				S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]

				K. A. Longo, J. A. Kennell, M. J. Ochocinska, S. E. Ross, W. S. Wright, and O. A. MacDougald Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors J. Biol. Chem., October 4, 2002; 277(41): 38239 - 38244. [Abstract] [Full Text] [PDF]

				Y. Yoshiko, K. Hirao, and N. Maeda Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1278 - C1286. [Abstract] [Full Text] [PDF]

				A. Serdaroglu, K. Gucuyener, S. Erdem, G. Kose, E. Tan, and C. Okuyaz Role of Apoptosis in Duchenne's Muscular Dystrophy J Child Neurol, January 1, 2002; 17(1): 66 - 68. [Abstract] [PDF]

				J. Nakae, Y. Kido, and D. Accili Distinct and Overlapping Functions of Insulin and IGF-I Receptors Endocr. Rev., December 1, 2001; 22(6): 818 - 835. [Abstract] [Full Text] [PDF]

				A. A. Sneddon, M. I. Delday, J. Steven, and C. A. Maltin Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70S6k in muscle showing clenbuterol-induced anabolism Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E676 - E682. [Abstract] [Full Text] [PDF]

				B. Zhu, G. Zhao, D. P. Witte, D. Y. Hui, and J. A. Fagin Targeted Overexpression of IGF-I in Smooth Muscle Cells of Transgenic Mice Enhances Neointimal Formation through Increased Proliferation and Cell Migration after Intraarterial Injury Endocrinology, August 1, 2001; 142(8): 3598 - 3606. [Abstract] [Full Text] [PDF]

				S. Dhara, P.G.L. Lalitkumar, J. Sengupta, and D. Ghosh Immunohistochemical localization of insulin-like growth factors I and II at the primary implantation site in the Rhesus monkey Mol. Hum. Reprod., April 1, 2001; 7(4): 365 - 371. [Abstract] [Full Text] [PDF]

				M. I. Kontaridis, X. Liu, L. Zhang, and A. M. Bennett SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis J. Cell Sci., January 6, 2001; 114(11): 2187 - 2198. [Abstract] [Full Text] [PDF]

				M. A. Lawlor and P. Rotwein Insulin-Like Growth Factor-Mediated Muscle Cell Survival: Central Roles for Akt and Cyclin-Dependent Kinase Inhibitor p21 Mol. Cell. Biol., December 1, 2000; 20(23): 8983 - 8995. [Abstract] [Full Text]

				J. R. Singleton, B. L. Baker, and A. Thorburn Dexamethasone Inhibits Insulin-Like Growth Factor Signaling and Potentiates Myoblast Apoptosis Endocrinology, August 1, 2000; 141(8): 2945 - 2950. [Abstract] [Full Text] [PDF]

				G. Zhao, M.-C. Monier-Faugere, M. C. Langub, Z. Geng, T. Nakayama, J. W. Pike, S. D. Chernausek, C. J. Rosen, L.-R. Donahue, H. H. Malluche, et al. Targeted Overexpression of Insulin-Like Growth Factor I to Osteoblasts of Transgenic Mice: Increased Trabecular Bone Volume without Increased Osteoblast Proliferation Endocrinology, July 1, 2000; 141(7): 2674 - 2682. [Abstract] [Full Text] [PDF]

				M. Fournier and M. I. Lewis Influences of IGF-I gene disruption on the cellular profile of the diaphragm Am J Physiol Endocrinol Metab, April 1, 2000; 278(4): E707 - E715. [Abstract] [Full Text] [PDF]

				D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets Endocrinology, March 1, 2000; 141(3): 1151 - 1157. [Abstract] [Full Text] [PDF]

				S.-K. Bae, M.-H. Bae, M.-Y. Ahn, M. J. Son, Y. M. Lee, M.-K. Bae, O.-H. Lee, B. C. Park, and K.-W. Kim Egr-1 Mediates Transcriptional Activation of IGF-II Gene in Response to Hypoxia Cancer Res., December 1, 1999; 59(23): 5989 - 5994. [Abstract] [Full Text] [PDF]

				P. Navarro, A. M. Valverde, M. Benito, and M. Lorenzo Activated Ha-ras Induces Apoptosis by Association with Phosphorylated Bcl-2 in a Mitogen-activated Protein Kinase-independent Manner J. Biol. Chem., July 2, 1999; 274(27): 18857 - 18863. [Abstract] [Full Text] [PDF]

				Y. Fujio, K. Guo, T. Mano, Y. Mitsuuchi, J. R. Testa, and K. Walsh Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival Mol. Cell. Biol., July 1, 1999; 19(7): 5073 - 5082. [Abstract] [Full Text] [PDF]

				L. Zhang, M. Kim, Y. H. Choi, B. Goemans, C. Yeung, Z. Hu, S. Zhan, P. Seth, and L. J. Helman Diminished G1 Checkpoint after gamma -Irradiation and Altered Cell Cycle Regulation by Insulin-like Growth Factor II Overexpression J. Biol. Chem., May 7, 1999; 274(19): 13118 - 13126. [Abstract] [Full Text] [PDF]

				C. Riou, H. Tonoli, F. Bernier-Valentin, R. Rabilloud, P. Fonlupt, and B. Rousset Susceptibility of Differentiated Thyrocytes in Primary Culture to Undergo Apoptosis after Exposure to Hydrogen Peroxide: Relation with the Level of Expression of Apoptosis Regulatory Proteins, Bcl-2 and Bax Endocrinology, May 1, 1999; 140(5): 1990 - 1997. [Abstract] [Full Text]

				J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik, and D. J. Hill Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia Endocrinology, May 1, 1999; 140(5): 2353 - 2363. [Abstract] [Full Text]

				D. D. Sarbassov and C. A. Peterson Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Regulate Extracellular Signal-Regulated Kinase-Dependent and -Independent Signaling Pathways during Myogenic Differentiation Mol. Endocrinol., December 1, 1998; 12(12): 1870 - 1878. [Abstract] [Full Text]

				J. Canicio, E. Gallardo, I. Illa, X. Testar, M. Palacin, A. Zorzano, and P. Kaliman p70 S6 Kinase Activation Is Not Required for Insulin-Like Growth Factor-Induced Differentiation of Rat, Mouse, or Human Skeletal Muscle Cells Endocrinology, December 1, 1998; 139(12): 5042 - 5049. [Abstract] [Full Text] [PDF]

				J. Petrik, E. Arany, T. J. McDonald, and D. J. Hill Apoptosis in the Pancreatic Islet Cells of the Neonatal Rat Is Associated with a Reduced Expression of Insulin-Like Growth Factor II that May Act as a Survival Factor Endocrinology, June 1, 1998; 139(6): 2994 - 3004. [Abstract] [Full Text] [PDF]

				S. Rousse, D. Montarras, C. Pinset, and C. Dubois Up-Regulation of Insulin-Like Growth Factor Binding Protein-5 Is Independent of Muscle Cell Differentiation, Sensitive to Rapamycin, But Insensitive to Wortmannin and LY294002 Endocrinology, April 1, 1998; 139(4): 1487 - 1493. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				D. D. Sarbassov, L. G. Jones, and C. A. Peterson Extracellular Signal-Regulated Kinase-1 and -2 Respond Differently to Mitogenic and Differentiative Signaling Pathways in Myoblasts Mol. Endocrinol., December 1, 1997; 11(13): 2038 - 2047. [Abstract] [Full Text] [PDF]

				M. Holzenberger, E. D. Jarvis, C. Chong, M. Grossman, F. Nottebohm, and C. Scharff Selective Expression of Insulin-Like Growth Factor II in the Songbird Brain J. Neurosci., September 15, 1997; 17(18): 6974 - 6987. [Abstract] [Full Text] [PDF]

				R. Rajah, B. Valentinis, and P. Cohen Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-beta 1 on Programmed Cell Death through a p53- and IGF-independent Mechanism J. Biol. Chem., May 2, 1997; 272(18): 12181 - 12188. [Abstract] [Full Text] [PDF]

				S. R. Plymate, V. L. Bae, L. Maddison, L. S. Quinn, and J. L. Ware Reexpression of the Type 1 Insulin-Like Growth Factor Receptor Inhibits the Malignant Phenotype of Simian Virus 40 T Antigen Immortalized Human Prostate Epithelial Cells Endocrinology, April 1, 1997; 138(4): 1728 - 1735. [Abstract] [Full Text] [PDF]

				S. A. Coolican, D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways J. Biol. Chem., March 7, 1997; 272(10): 6653 - 6662. [Abstract] [Full Text] [PDF]

				H. Zhang, H. Hoff, and C. Sell Insulin-like Growth Factor I-mediated Degradation of Insulin Receptor Substrate-1 Is Inhibited by Epidermal Growth Factor in Prostate Epithelial Cells J. Biol. Chem., July 14, 2000; 275(29): 22558 - 22562. [Abstract] [Full Text] [PDF]

				L. L. Tortorella, D. J. Milasincic, and P. F. Pilch Critical Proliferation-independent Window for Basic Fibroblast Growth Factor Repression of Myogenesis via the p42/p44 MAPK Signaling Pathway J. Biol. Chem., April 20, 2001; 276(17): 13709 - 13717. [Abstract] [Full Text] [PDF]

				Q. Kang, Y. Cao, and A. Zolkiewska Direct Interaction between the Cytoplasmic Tail of ADAM 12 and the Src Homology 3 Domain of p85alpha Activates Phosphatidylinositol 3-Kinase in C2C12 Cells J. Biol. Chem., June 29, 2001; 276(27): 24466 - 24472. [Abstract] [Full Text] [PDF]